A critical advance in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This vital malignant inhibitor protein is frequently inactivated in several types of cancer, leading uncontrolled https://socialmediaentry.com/story7465469/nanobodies-revive-tumor-suppressor-p53-new-potential-approach-for-tumor-therapy